Joachim Gullbo, MD, PhD, and Adjunct Professor

WNTresearch   →  Team   →  Advisory Board   →  Joachim Gullbo, MD, PhD, and Adjunct Professor

Joachim Gullbo, MD, PhD, and Adjunct Professor

Joachim Gullbo, MD, PhD, and Adjunct Professor of Clinical Pharmacology at Uppsala University, has a solid scientific background in the development and evaluation of anticancer drugs, from preclinical research to clinical trials. He is co-author of more than 85 scientific publications in the field of cancer.

Joachim Gullbo is a Swedish clinical specialist in clinical pharmacology and oncology, and was previously head of the oncology section at Uppsala University Hospital. He is currently Medical Monitor at Theradex Oncology in Princeton, USA. Joachim is one of the founders of Oncopeptides where he now remains as scientific advisor.